+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study



Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study



Alimentary Pharmacology and Therapeutics 44(6): 592-600



Traditionally, functional gastrointestinal disorders (FGIDs) are conceptualised as originating in the brain via stress pathways (brain-to-gut). It is uncertain how many with irritable bowel syndrome (IBS) and functional dyspepsia (FD) have a gut origin of symptoms (gut-to-brain pathway). To determine if there is a distinct brain-to-gut FGID (where psychological symptoms begin first) and separately a distinct gut-to-brain FGID (where gut symptoms start first). A prospective random population sample from Newcastle, Australia who responded to a validated survey in 2012 and completed a 1-year follow-up survey (n = 1900). The surveys contained questions on Rome III IBS and FD and the Hospital Anxiety and Depression Scale. We found that higher levels of anxiety and depression at baseline were significant predictors of developing IBS (OR = 1.31; 95% CI 1.06-1.61, P = 0.01; OR = 1.54; 95% CI 1.29-1.83, P < 0.001) and FD (OR = 1.28; 95% CI 1.05-1.55, P = 0.01; OR = 1.55, 95% CI 1.32-1.83, P < 0.001), respectively, at the 1-year follow-up. Among those people who did not have elevated levels of anxiety and depression at baseline, subjects at baseline with documented IBS (mean difference 0.34; 95% CI 0.13-0.55, P = 0.002; 0.81; 95% CI 0.47-1.15, P < 0.001) and FD (0.38; 95% CI 0.14-0.63, P = 0.002; 0.92; 95% CI 0.57-1.27, P < 0.001), reported significantly higher levels of anxiety and depression at the 1-year follow-up. We calculated in one-third of individuals a mood disorder precedes FGID but in two-thirds an FGID precedes the mood disorder. While brain-gut pathways are bidirectional, a major subset begin with gut symptoms first and only then psychological distress develops, implicating primary gut mechanisms as drivers of the gut and extra-intestinal features in many cases.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057822628

Download citation: RISBibTeXText

PMID: 27444264

DOI: 10.1111/apt.13738


Related references

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Alimentary Pharmacology & Therapeutics 2019, 2019

Evidence that the irritable bowel syndrome and functional dyspepsia are a single disorder A longitudinal, population-based study. Gastroenterology 110(4 Suppl. ): A26, 1996

Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. European Journal of Gastroenterology and Hepatology 18(10): 1101-1109, 2006

Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: a systematic analysis of evidence for the herbal preparation Iberogast. Wiener Medizinische Wochenschrift 154(21-22): 528-534, 2005

Mo2043 Increased Pain Hypersensitivity in Women With Irritable Bowel Syndrome and Functional Dyspepsia Explained by Psychological Factors: A Prospective Birth Cohort Population. Gastroenterology 148(4): S-777-S-778, 2015

Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study. Bmc Gastroenterology 17(1): 65, 2018

Mo1632 Sleep Disturbances in People With Irritable Bowel Syndrome (IBS) and Functional Dyspepsia (FD) Are Not Explained by Psychological or Lifestyle Factors. a Population-Based Study. Gastroenterology 150(4): S736-S737, 2016

Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis. Microbiome 7(1): 45, 2019

Psychosocial predictors of irritable bowel syndrome and functional dyspepsia in the general population. Gastroenterology 120(5 Suppl. 1): A 758, 2001

Is There Enough Evidence for the Association of GNβ3 C825T Polymorphism With Functional Dyspepsia and Irritable Bowel Syndrome?. Journal of Neurogastroenterology and Motility 18(3): 348-349, 2012

Iberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome)--from phytomedicine to "evidence based phytotherapy." A systematic review. Forschende Komplementarmedizin und Klassische Naturheilkunde 9(Suppl. 1): 1-20, 2003

The epidemiology of irritable bowel syndrome: Symptom development over a 3-year period in Denmark. A prospective, population-based cohort study. Neurogastroenterology and Motility 29(4), 2016

Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. Journal of Gastroenterology 50(6): 601-613, 2016

Quality of life at dyspepsia and irritable bowel syndrome: population-based studies. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(3): 27-31, 2010

Irritable Bowel Syndrome and Upper Dyspepsia among the Elderly: A Study of Symptom Clusters in a Random 70 Year Old Population. European Journal of Epidemiology 12(2): 199-204, 1996